Related Experiment Video

Updated: Dec 20, 2025

A Comparative Approach to Characterize the Landscape of Host-Pathogen Protein-Protein Interactions
13:56

A Comparative Approach to Characterize the Landscape of Host-Pathogen Protein-Protein Interactions

Published on: July 18, 2013

11.5K

The Landscape of Human Cancer Proteins Targeted by SARS-CoV-2

Beril Tutuncuoglu1,2,3,4,5, Merve Cakir1,2,3,4,5, Jyoti Batra1,2,3,4

  • 1Department of Cellular and Molecular Pharmacology, University of California, San Francisco, California.

Cancer Discovery
|May 24, 2020
PubMed

Insights

Researchers identified cancer-promoting pathways hijacked by the SARS-CoV-2 virus. This discovery aids in repurposing cancer drugs for COVID-19 treatment and understanding long-term health effects.

Area of Science:

  • Virology
  • Oncology
  • Drug Discovery

Background:

  • The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus interacts with human proteins.
  • Understanding these host-virus interactions is crucial for developing effective treatments.

Purpose of the Study:

  • To identify oncogenic pathways at the host-virus interface of SARS-CoV-2.
  • To facilitate drug repurposing for COVID-19 treatment and address potential long-term complications.

Main Methods:

  • Analysis of SARS-CoV-2 human protein-protein interaction maps.
  • Identification of hijacked oncogenic pathways.

Main Results:

  • Several oncogenic pathways were identified as targets exploited by SARS-CoV-2.
  • These pathways represent potential targets for therapeutic intervention.

Conclusions:

  • The study provides insights into the molecular mechanisms of SARS-CoV-2 infection.
  • Findings support the application of cancer biology knowledge for COVID-19 drug repurposing and management of sequelae.

More Related Videos

Navigating the Mass Spectrometry-Based Proteomic Data Using Free Computational Tools07:01

Navigating the Mass Spectrometry-Based Proteomic Data Using Free Computational Tools

Published on: August 19, 2025

650
Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors08:08

Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors

Published on: February 27, 2015

16.8K

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.0K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.1K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.0K